Cargando…
Evaluation of the SharkCore(®) needle for EUS-guided core biopsy of pancreatic neuroendocrine tumors
BACKGROUND AND OBJECTIVES: EUS guided core biopsy was once rarely performed but is now entering mainstream practice. Neuroendocrine tumors often warrant core biopsy as sufficient tissue must be obtained to allow for special staining to ensure a correct diagnosis. Traditionally these lesions were sam...
Autores principales: | Witt, Benjamin L., Factor, Rachel E., Chadwick, Barbara E., Caron, Justin, Siddiqui, Ali A., Adler, Douglas G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199904/ https://www.ncbi.nlm.nih.gov/pubmed/29623910 http://dx.doi.org/10.4103/eus.eus_51_17 |
Ejemplares similares
-
A Multicenter comparative trial of a novel EUS-guided core biopsy needle (SharkCore(™)) with the 22-gauge needle in patients with solid pancreatic mass lesions
por: Naveed, Mariam, et al.
Publicado: (2018) -
Initial experience with a novel EUS-guided core biopsy needle (SharkCore): results of a large North American multicenter study
por: DiMaio, Christopher J., et al.
Publicado: (2016) -
EUS-guided fine-needle core liver biopsy with a modified one-pass, one-actuation wet suction technique comparing two types of EUS core needles
por: Nieto, Jose, et al.
Publicado: (2020) -
A multicenter evaluation of a new EUS core biopsy needle: Experience in 200 patients
por: Adler, Douglas G., et al.
Publicado: (2019) -
EUS fine-needle pancreatic core biopsy can determine eligibility for tumor-agnostic immunotherapy
por: Gleeson, Ferga C., et al.
Publicado: (2018)